Search

Search Language

日本語 / Japanese | Use language selector above (below, on mobile) to search additional languages

Open filter

Selected filters
x(Life Sciences & HealthTech)

110 items matching filters

Insight

DEA Issues Third Extension of Telemedicine Prescribing Flexibilities

by Amy M. Joseph, Jeremy D. Sherer, Melania Jankowski and Anna Booth | January.02.2025

The Third Extension allows providers to continue prescribing controlled substances without a prior in-person examination through December 31, 2025.

Insight

Life Sciences Snapshot – Q4 2024 – A Quarterly Report on Financing Trends

December.20.2024

Healthtech Horizons: Navigating Regulation, Investment, and Strategy in a Transforming Market

Insight

The Sunshine Act: 10 Things to Know

by Amy M. Joseph and Emily Brodkin | December.11.2024

For some medical device companies and GPOs, reporting financial info to the U.S. government is now a routine part of business.

Insight

Developing and Patenting AI Inventions: 5 Things for Biotech Companies to Consider

by , David Sharrow and Daniela Glaser | October.10.2024

Biotech firms must assess AI's impact on research protection. Recent U.S. PTO guidance aids in scientific development and legal matters.

Life Sciences Snapshot – Q2 2024 – A Quarterly Report on Financing Trends

Insight

Life Sciences Snapshot – Q3 2024 – A Quarterly Report on Financing Trends

October.07.2024

Navigating ARPA-H

ai and healthcare - healthtech - digital life sciences icons

Insight

U.S. States Begin Regulating Generative Artificial Intelligence in Health Care

by Amy M. Joseph, Jeremy D. Sherer, Emily Brodkin and Melania Jankowski | October.03.2024

The health care industry has used AI for decades, but the rise of generative AI raises questions about how to regulate the technology.

Insight

Earnout Payments in Life Sciences and HealthTech M&A: Seller Beware

by Stephen Thau and Mike O'Donnell | September.26.2024

Earnout payments can be tricky. Learn about key negotiating tips and lessons from a recent case.

Insight

Texas Attorney General Reaches Novel Generative AI Settlement: What Health Tech Companies Need to Know

by Thora Johnson, Alyssa Wolfington, Amy M. Joseph, Jeremy D. Sherer, Emily Brodkin and Melania Jankowski | September.24.2024

The Texas Attorney General is once again signaling the office’s intent to enforce the state’s privacy and consumer protection laws.

Insight

Navigating University Technology Licensing for Startups: Key Considerations

by Stephen Thau and David Sharrow | September.23.2024

Licensing university technology to start a company is complex. Founders should be aware of key challenges and opportunities in the process.

Insight

Orrick Speaks: Jeremy Sherer Explores California AI Legislation with Modern Healthcare

by Jeremy D. Sherer | September.23.2024

Proposed AI legislation in California may have big implications in health care.

Insight

Generative AI and Health Care: Key Takeaways

by Thora Johnson, Amy M. Joseph and Georgia C. Ravitz | September.20.2024

Generative AI is converging with every sector – and health care is no exception.

The EU AI Act Series: What Life Sciences and Digital Health Companies Should Know

Insight

The EU AI Act: What Life Sciences and Digital Health Companies Should Know

by Julia Apostle, Daniel Kadin and David Sharrow | September.13.2024

EU AI Act is a landmark piece of legislation that establishes the first comprehensive framework for regulating the use of artificial intelligence.